Study of the Colonic Carriage of Staphylococcus Aureus in a Prospective Cohort of Patients Undergoing Endoscopic Screening for Digestive Cancer in the University Hospital of Saint-Etienne (ColoStaph)

Study of the Colonic Carriage of Staphylococcus Aureus in a Prospective Cohort of Patients Undergoing Endoscopic Screening for Digestive Cancer in the University Hospital of Saint-Etienne.

Epidemiological study aiming to describe the carriage (nasal, throat, groin, rectal and colonic) of S. aureus in patients without chronic digestive disease who are going to have a colonoscopy for cancer screening. The carriage will be analyzed globally and the similarity of strains isolated from each site will be analyzed using molecular tools. The aim of this study is to better estimate the digestive reservoir of S. aureus to better prevent endogenous infections due to this bacterium.

Study Overview

Status

Completed

Study Type

Interventional

Enrollment (Actual)

112

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Saint-Etienne, France, 42055
        • CHU Saint-Etienne

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patient affiliated to French social security
  • Written consent of the patient
  • Patient needing a colonoscopy in the University Hospital of Saint-Etienne, France

Exclusion Criteria:

  • Patient who decline to participate to the study
  • Patient in the incapacity to give consent
  • Patient receiving treatment with anticoagulant or antiaggregant platelets
  • Patients with a known haemostatic disorder
  • Pregnant woman
  • Patients with a chronic disease of the gastrointestinal tract
  • Patients receiving long-term corticosteroid
  • Patient receiving anti staphylococcal antibiotics

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Patients undergoing a colonoscopy
Staphylococcus aureus carriage is measured in nose, throat, colon, rectum and groin
nasal, throat, rectal and groin sampling with swabs. Colonic sampling by colonic biopsy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of patient with Staphylococcus aureus colonic carriage
Time Frame: Day 1
Staphylococcus aureus carriage in the colon is measured by biopsy
Day 1

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of patient with similar Staphylococcus aureus strains in the nose and in the rectum
Time Frame: Day 1
Staphylococcus aureus carriage in the rectum and in the nose is measured by swab culture
Day 1
Number of patient with Staphylococcus aureus carriage in the nose
Time Frame: Day 1
Staphylococcus aureus carriage in the nose is measured by swab culture.
Day 1
Number of patient with Staphylococcus aureus carriage in the throat
Time Frame: Day 1
Staphylococcus aureus carriage in the throat is measured by swab culture.
Day 1
Number of patient with Staphylococcus aureus carriage in the groin
Time Frame: Day 1
Staphylococcus aureus carriage in the groin is measured by swab culture.
Day 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Philippe Berthelot, PhD, CHU Saint-Etienne

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 2, 2015

Primary Completion (Actual)

October 20, 2017

Study Completion (Actual)

October 20, 2017

Study Registration Dates

First Submitted

July 15, 2015

First Submitted That Met QC Criteria

July 16, 2015

First Posted (Estimate)

July 20, 2015

Study Record Updates

Last Update Posted (Actual)

September 28, 2018

Last Update Submitted That Met QC Criteria

September 27, 2018

Last Verified

September 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • 1408023
  • 2014-A00755-42 (Other Identifier: ANSM)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on STAPHYLOCOCCAL INFECTIONS

Clinical Trials on Staphylococcus aureus carriage

3
Subscribe